Drug Profile
Bivalent Norovirus vaccine - Vaxart
Alternative Names: Bivalent GII.4 vaccine - Vaxart; GI.1 oral vaccine tablet + GII.4 oral vaccine tablet; Norovirus GI.1 vaccine + Norovirus GII.4 vaccine; VP1 based bivalent oral tablet vaccine - Vaxart; VXA-G1.1-NN + VXA-G2.4-NSLatest Information Update: 21 Mar 2024
Price :
$50
*
At a glance
- Originator Vaxart
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Norovirus infections